한국어
English
日本語
中文(简体)
Tenofovir Alafenamide Tablet (Tenofovir Alafenamide Fumarate)
31.2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Tenofovir alafenamide succinate is an antiviral ingredient used in the treatment of chronic hepatitis B.
MFDS ingredient code M279141
Tenofovir alafenamide succinate belongs to the antiviral class of agents and is used to suppress viral replication in patients with chronic hepatitis B. This ingredient is converted into its active form within the liver, effectively blocking viral replication.
This ingredient interferes with the synthesis of viral DNA within liver cells, preventing the virus from replicating. This helps to reduce liver damage and slows the progression of the disease.
Approved uses differ by product. Check each product's information for its actual use.
Tenofovir alafenamide succinate is activated more efficiently within liver cells compared to existing tenofovir formulations, allowing it to be effective at lower doses. This results in a reduced risk of side effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.